Precision Medicine in Thoracic Surgery: Esophageal Cancer

Area of Science:

• Oncology
• Gastroenterology
• Medical Research

Background:

• Esophageal cancer is a significant health concern in the US, ranking 18th in incidence and 14th in mortality.
• Survival rates for esophageal cancer remain low, around 20% at 5 years.
• Two primary histologic subtypes exist: esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), each with distinct epidemiological links.

Purpose of the Study:

• To provide an overview of esophageal cancer, including its incidence, mortality, and survival rates.
• To differentiate between the two main histologic subtypes and their associated risk factors.
• To outline current diagnostic and treatment strategies and highlight future research directions.

Main Methods:

• Review of epidemiological data on esophageal cancer incidence and mortality.
• Description of the characteristics and risk factors for EAC and ESCC.
• Summary of diagnostic modalities such as endoscopic ultrasound, CT, and PET scans.
• Overview of current multimodal treatment approaches including surgery, chemoradiotherapy, and systemic therapies.

Main Results:

• Esophageal cancer presents a considerable challenge with poor survival outcomes.
• EAC is associated with Western lifestyle factors like obesity and GERD, while ESCC is linked to global lifestyle factors including tobacco and alcohol use.
• Accurate staging is crucial for guiding treatment decisions.

Conclusions:

• Esophageal cancer requires a multimodal treatment approach tailored to the specific subtype and stage.
• Ongoing research into molecular targets and immunotherapies holds promise for enhancing treatment efficacy and patient survival.
• Further advancements are expected in the management and prognosis of esophageal cancer.